TY - JOUR
T1 - Hip resurfacing arthroplasty
T2 - Risk factors for failure over 25 years
AU - Yue, Eric J.
AU - Cabanela, Miguel E.
AU - Duffy, Gavan P.
AU - Heckman, Michael G.
AU - O'Connor, Mary I.
PY - 2009/4
Y1 - 2009/4
N2 - Many early metal-on-polyethylene hip resurfacing arthroplasty designs were abandoned after reports of high short-term and midterm failure rates. To investigate factors associated with failure, we retrospectively reviewed our experience with early-design hip resurfacing implants in 75 patients during a 25-year period (median followup, 7.9 years; range, 0.1-25.2 years). Implant failure was defined as revision for any reason. One of 75 patients was lost to followup. The estimated rate of implant survival was 73% at 5 years, 34% at 10 years, 27% at 15 years, 12% at 20 years, and 8% at 25 years. Of the many clinical and radiographic factors considered, only age, implant type, and gender were associated with implant survival independent of other variables considered. Hip resurfacing arthroplasty showed poor overall long-term survival in this series. Particular attention should be paid to the identified risk factors as long-term followup data become available for modern designs. Level of Evidence: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.
AB - Many early metal-on-polyethylene hip resurfacing arthroplasty designs were abandoned after reports of high short-term and midterm failure rates. To investigate factors associated with failure, we retrospectively reviewed our experience with early-design hip resurfacing implants in 75 patients during a 25-year period (median followup, 7.9 years; range, 0.1-25.2 years). Implant failure was defined as revision for any reason. One of 75 patients was lost to followup. The estimated rate of implant survival was 73% at 5 years, 34% at 10 years, 27% at 15 years, 12% at 20 years, and 8% at 25 years. Of the many clinical and radiographic factors considered, only age, implant type, and gender were associated with implant survival independent of other variables considered. Hip resurfacing arthroplasty showed poor overall long-term survival in this series. Particular attention should be paid to the identified risk factors as long-term followup data become available for modern designs. Level of Evidence: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.
UR - http://www.scopus.com/inward/record.url?scp=62449148297&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=62449148297&partnerID=8YFLogxK
U2 - 10.1007/s11999-008-0506-y
DO - 10.1007/s11999-008-0506-y
M3 - Article
C2 - 18813892
AN - SCOPUS:62449148297
SN - 0009-921X
VL - 467
SP - 992
EP - 999
JO - Clinical orthopaedics and related research
JF - Clinical orthopaedics and related research
IS - 4
ER -